Lost in translation: the gap between what we know and what we do about cardiovascular disease

Almost one million Australians at high risk of cardiovascular disease may not have been receiving the recommended combination of bloodpressure-lowering and lipid- Lowering medications, although their use has long been recommended by the national peak body on the basis of level A evidence.